In November 2014, the International Society of Urological Pathology (ISUP) convened a consensus meeting in Chicago, USA to consider grading criteria for prostatic adenocarcinoma [1]. The primary purpose and main outcome of this meeting was a recommendation that not only should the Gleason score of prostate cancer be reported but that grading should also incorporate a 5-tier grade based on a grouping of Gleason scores. The outcome of the conference has resulted in widespread confusion as to the grading nomenclature. This has weighed heavily on the prostate cancer literature to the extent that the time has now come to question the scientific value of the score grouping.
This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 February 2021.
All research outputs
#2,449,593
of 34,547,233 outputs
Outputs from British Journal of Urology
#585
of 8,063 outputs
Outputs of similar age
#51,074
of 571,047 outputs
Outputs of similar age from British Journal of Urology
#12
of 70 outputs
Altmetric has tracked 34,547,233 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,063 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.5. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 571,047 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 70 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.
